Recursion Pharmaceuticals (NASDAQ:RXRX) stock is one of those lesser-known mid-cap biotech plays that investors may be ...

It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.

Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

Recursion reported second-quarter revenue of $19.22 million, beating analyst estimates of $16.23 million, according to ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Tuesday reported a loss of $171.9 million in its second quarter. On a per-share basis, the Salt Lake City-based ...

This paper proposes a recursive algorithm for estimating the adaptive function coefficients autoregressive (AFAR) models. Due to its recursive nature, its arithmetic complexity is relatively lower ...

Terraform module, which creates almost all supported AWS Lambda resources as well as taking care of building and packaging of required Lambda dependencies for functions and layers. This Terraform ...

Node-sass is a library that provides binding for Node.js to LibSass, the C version of the popular stylesheet preprocessor, Sass. It allows you to natively compile .scss files to css at incredible ...